Cargando…
Clinical trials for coronavirus disease 2019: What is being evaluated and what is not
Since the report of the first case of coronavirus disease 2019 (COVID-19) in China in late December 2019, there have been 204 610 cases worldwide as of 18 March, 2020. As part of the response to this outbreak, there has been an impressive amount of research undertaken to better characterize the dise...
Autores principales: | Arabi, Yaseen M., Asseri, Ayed, Webb, Steve, Marshall, John, Al Moamary, Mohamed S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259392/ https://www.ncbi.nlm.nih.gov/pubmed/32489437 http://dx.doi.org/10.4103/atm.ATM_99_20 |
Ejemplares similares
-
Shifting paradigm: From “No Code” and “Do-Not-Resuscitate” to “Goals of Care” policies
por: Arabi, Yaseen M., et al.
Publicado: (2018) -
What is the optimal usage of coronavirus disease 2019 convalescent plasma donations?
por: Focosi, Daniele, et al.
Publicado: (2021) -
Coronavirus Disease 2019 and Acute Kidney Injury: What Have We Learned?
por: Husain-Syed, Faeq, et al.
Publicado: (2021) -
The Coronavirus Disease 2019 (COVID-19) Pandemic in Africa: What Can We Expect?
por: Maoujoud, Omar, et al.
Publicado: (2020) -
What are we doing in the dermatology outpatient department amidst the raging of the 2019 novel coronavirus?
por: Chen, Yusha, et al.
Publicado: (2020)